Clinical trial
Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction
NCT00398632 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00398632 |
|---|---|
| Title | Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction |
| Official title | Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction |
| Lead sponsor | Stanford University, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Duloxetine |
| Enrollment | 6 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Nov 14, 2006 |
| Last update posted | Nov 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: